Let Me Tell You More About My Depressed, Miserable Existence
By Depressed Jane on February 21, 2006
Daniel Schultz, director of FDA’s Center for Devices and Radiological Health, overruled unanimous recommendations of FDA scientists and administrators in approving a surgically implantable nerve stimulator for the treatment of severe depression, according to a … click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 17, 2006
The results of the “Sequenced Treatment Alternatives to Relieve Depression” (STAR*D) study are being released in the January 2006 edition of the American Journal Of Psychiatry (AJP), a monthly psychiatric journal of the American Psychiatric Association (APA). The AJP article, Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice, finds that only 30 percent of chronically depressed patients ac… click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 17, 2006
For the more than 18 million Americans who suffer from depressive illnesses, the best pharmacological treatments are those that increase levels of serotonin, the brain chemical that regulates mood, sleep and memory. New research by an international team of scientists, led by Rockefeller University researchers in Paul Greengard’s laboratory of Molecular and Cellular Neuroscience, shows that a gene called p11 is closely related to serotonin transmission in the brain — and may play a key role … click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 17, 2006
Women on antidepressants who stop taking their medication when they become pregnant risk relapsing into depression, according to a study published in the Feb. 1 edition of the Journal of the American Medical Association, … click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 17, 2006
The number of adverse reactions reported by UK doctors to the antidepressant paroxetine – often know by its brand name Seroxat – rose by 61 per cent after three editions of the BBC’s award-winning current affairs programme Panorama explored increasing concerns about the drug. Research just published in the British Journal of Clinical Pharmacology shows a sudden increase in reports immediately after each of the three programmes were aired in the UK in October 2002… click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 17, 2006
(in French at the bottom of this page) Researchers have discovered a new drug that raises the level of endocannabinoids–the ‘brain’s own cannabis’–providing anti-depressant effects. The new research published in this week’s Proceedings of the National Academy of Sciences (PNAS), suggests the new drug, called URB597, could represent a safer alternative to cannabis for the treatment of pain and depression, and open the door to new and improved treatments for clinical depression–… click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 16, 2006
Electroconvulsive therapy (ECT) — shock treatment —improves quality of life in patients with major depression, and that improved quality of life continues for six months, according to a report in the February Journal of Affective Disorders.The study was conducted in seven hospitals in New York City — two private psychiatric hospitals, three community hospitals and two academic medical centers, said W… click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 16, 2006
Electroconvulsive therapy (ECT) — shock treatment —improves quality of life in patients with major depression, and that improved quality of life continues for six months, according to a report in the February Journal of Affective Disorders.The study was conducted in seven hospitals in New York City — two private psychiatric hospitals, three community hospitals and two academic medical centers, said W… click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 15, 2006
The number of adverse reactions reported by UK doctors to the antidepressant paroxetine – often know by its brand name Seroxat – rose by 61 per cent after three editions of the BBC’s award-winning current affairs programme Panorama explored increasing concerns about the drug. Research just published in the British Journal of Clinical Pharmacology shows a sudden increase in reports immediately after each of the three programmes were aired in the UK in October 2002, May 2003 and October 2004… click link for more info.
Popularity: unranked [?]
By Depressed Jane on February 13, 2006
A lifetime history of depression is associated with increased plaques and tangles in the brains of those with Alzheimer’s disease and more rapid cognitive decline, according to a study by researchers at the Alzheimer’s Disease Research Center at Mount Sinai School of Medicine. The study is published in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals… click link for more info.
Popularity: unranked [?]
